Testosterone Therapy Demonstrates CV Safety in Testosterone Deficiency
Testosterone therapy was not associated with an increased risk for cardiovascular events among patients with testosterone deficiency.
Related Articles
Underrepresentation of older adults in diabetes and kidney disease trials
Management of older adults with type 2 diabetes and chronic kidney disease is complex. These individuals often have multiple comorbidities, take several medications, and are…
Transepidermal water loss may predict wound recurrence for diabetic foot ulcers
Researchers identified a biomarker that may predict the recurrence of a diabetic foot ulcer that had previously healed. In a study published in Diabetes Care,…
‘The time for change is now’: Lancet report may reshape how medicine views, treats obesity
New recommendations from an international commission could dramatically change the way obesity is diagnosed, treated and discussed worldwide.In January, an international group of 58 experts…
New Study Questions BMI Accuracy in Childhood Obesity Screening – Endocrine News
A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in…
Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement
Placement of a dental implant in a patient on antiresorptive therapy has been hypothesized to increase the risk of medication-related osteonecrosis of the jaw (MRONJ)…
To Freeze or Not to Freeze? Discussing Fertility Preservation With Trans Folks
When discussing fertility preservation options among transgender patients, it is critical to keep barriers to access in mind.
AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications – Endocrine News
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s…
Successful Treatment of Hypothalamic Obesity with Tirzepatide
Hypothalamic obesity (HO) is a rare but severe form of obesity characterized by hypothalamic damage resulting in hyperphagia and decreased energy expenditure. Tumors involving the…
Very high or low levels of vitamin D appear to raise risk for falls, fractures
ORLANDO — Both very low and very high levels of vitamin D appear to increase risk for falls and fractures, a speaker said at the…